Search Results - "ODINK, DEBRA" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

ST-2560, a selective inhibitor of the Na V 1.7 sodium channel, affects nocifensive and cardiovascular reflexes in non-human primates

ST-2560, a selective inhibitor of the Na V 1.7 sodium channel, affects nocifensive and cardiovascular reflexes in non-human primates

by Mulcahy, John V, Beckley, Jacob T, Klas, Sheri D, Odink, Debra A, Delwig, Anton, Pajouhesh, Hassan, Monteleone, Dennis, Zhou, Xiang, Du Bois, Justin, Yeomans, David C, Luu, George, Hunter, John C
Published in British journal of pharmacology (01.09.2024)

Get more information

Journal Article

Abstract P4-08-21: Development of novel inhibitors of the serum/glucocorticoid induced kinase (SGK) family to address limitations of AKT/PI3K/mTOR inhibitors in breast cancer

Abstract P4-08-21: Development of novel inhibitors of the serum/glucocorticoid induced kinase (SGK) family to address limitations of AKT/PI3K/mTOR inhibitors in breast cancer

by Labit, Delphine, Pradhananga, Sabindra, Khalifa, Maroua, Blackburn, Emma, Sajid, Naheed, Vidal, Marc, Odink, Debra, Campeau, Eric
Published in Cancer research (Chicago, Ill.) (01.03.2023)

Get full text

Journal Article

Synthesis and structure of chromium antimony triselenide (CrSbSe3): a pseudo-one-dimensional ferromagnet

Synthesis and structure of chromium antimony triselenide (CrSbSe3): a pseudo-one-dimensional ferromagnet

by Odink, Debra A, Carteaux, Veronique, Payen, Christophe, Ouvrard, Guy
Published in Chemistry of materials (01.02.1993)

Get full text

Journal Article

Intercalation of pyridine into the layered samarium sulfide iodide (SmSI) structure of ytterbium oxide chloride (YbOCl)

Intercalation of pyridine into the layered samarium sulfide iodide (SmSI) structure of ytterbium oxide chloride (YbOCl)

by Odink, Debra A, Song, Kang, Kauzlarich, Susan M
Published in Chemistry of materials (01.07.1992)

Get full text

Journal Article

Calcium gallium arsenide, Ca14GaAs11: A new compound containing discrete GaAs4 tetrahedra and a hypervalent As3 polyatomic unit

Calcium gallium arsenide, Ca14GaAs11: A new compound containing discrete GaAs4 tetrahedra and a hypervalent As3 polyatomic unit

by Kauzlarich, Susan M, Thomas, Michele M, Odink, Debra A, Olmstead, Marilyn M
Published in Journal of the American Chemical Society (01.09.1991)

Get full text

Journal Article

TREATMENT OF MAJOR ADVERSE CARDIAC EVENTS AND ACUTE CORONARY SYNDROME USING SECRETORY PHOSPHOLIPASE A2 (SPLA2) INHIBITOR OR SPLA2 INHIBITOR COMBINATION THERAPIES

TREATMENT OF MAJOR ADVERSE CARDIAC EVENTS AND ACUTE CORONARY SYNDROME USING SECRETORY PHOSPHOLIPASE A2 (SPLA2) INHIBITOR OR SPLA2 INHIBITOR COMBINATION THERAPIES

by HISLOP COLIN, ODINK DEBRA, TRUEX PAUL, TRIAS JOAQUIM
Year of Publication 20.09.2011

Get full text

Patent

Buffered Formulations Of Exendin (9-39)

Buffered Formulations Of Exendin (9-39)

by Smith, Christine M.N, McLaughlin, Tracey L, XIONG, Xiaofeng, CRAIG, Colleen M, ODINK, Debra
Year of Publication 08.02.2024

Get full text

Patent

TREATMENT OF CARDIOVASCULAR DISEASE AND DYSLIPIDEMIA USING SECRETORY PHOSPHOLIPASE A2 (SPLA2) INHIBITORS AND SPLA2 INHIBITOR COMBINATION THERAPIES

TREATMENT OF CARDIOVASCULAR DISEASE AND DYSLIPIDEMIA USING SECRETORY PHOSPHOLIPASE A2 (SPLA2) INHIBITORS AND SPLA2 INHIBITOR COMBINATION THERAPIES

by HISLOP COLIN, FRASER BERNADINE, ODINK DEBRA, TRUEX PAUL, EACHO PATRICK, GOULD KENNETH, MOSIOR MARIAN, CHADWICK SCOTT, TRIAS JOAQUIM
Year of Publication 11.10.2010

Get full text

Patent

BUFFERED FORMULATIONS OF EXENDIN (9-39)

BUFFERED FORMULATIONS OF EXENDIN (9-39)

by McLaughlin, Tracey L, Odink, Debra, Xiong, Xiaofeng, Smith, Christine M. N, Craig, Colleen M
Year of Publication 19.10.2023

Get full text

Patent

Methods of using buffered formulations of exendin (9-39)

Methods of using buffered formulations of exendin (9-39)

by McLaughlin, Tracey L, Odink, Debra, Xiong, Xiaofeng, Smith, Christine M. N, Craig, Colleen M
Year of Publication 29.08.2023

Get full text

Patent

Buffered formulations of exendin (9-39)

Buffered formulations of exendin (9-39)

by McLaughlin, Tracey L, Odink, Debra, Xiong, Xiaofeng, Smith, Christine M. N, Craig, Colleen M
Year of Publication 29.06.2023

Get full text

Patent

BUFFERED FORMULATIONS OF EXENDIN (9-39)

BUFFERED FORMULATIONS OF EXENDIN (9-39)

by XIONG, Xiaofeng, SMITH, Christine M.N, CRAIG, Colleen M, ODINK, Debra
Year of Publication 05.08.2020

Get full text

Patent

Buffered Formulations Of Exendin (9-39)

Buffered Formulations Of Exendin (9-39)

by Smith, Christine M.N, Odink, Debra, Xiong, Xiaofeng, Craig, Colleen M
Year of Publication 05.03.2020

Get full text

Patent

Buffered Formulations Of Exendin (9-39)

Buffered Formulations Of Exendin (9-39)

by Smith, Christine M.N, McLaughlin, Tracey L, Odink, Debra, Xiong, Xiaofeng, Craig, Colleen M
Year of Publication 14.10.2021

Get full text

Patent

BUFFERED FORMULATIONS OF EXENDIN (9-39)

BUFFERED FORMULATIONS OF EXENDIN (9-39)

by XIONG, Xiaofeng, SMITH, Christine M.N, CRAIG, Colleen M, ODINK, Debra
Year of Publication 25.09.2019

Get full text

Patent

Buffered formulations of exendin (9-39)

Buffered formulations of exendin (9-39)

by McLaughlin, Tracey L, Odink, Debra, Xiong, Xiaofeng, Smith, Christine M. N, Craig, Colleen M
Year of Publication 01.06.2021

Get full text

Patent

Buffered formulations of exendin (9-39)

Buffered formulations of exendin (9-39)

by Smith, Christine M.n, Odink, Debra, Xiong, Xiaofeng, Craig, Colleen M
Year of Publication 04.07.2019

Get full text

Patent

BUFFERED FORMULATIONS OF EXENDIN (9-39)

BUFFERED FORMULATIONS OF EXENDIN (9-39)

by XIONG, Xiaofeng, SMITH, Christine M.N, CRAIG, Colleen M, ODINK, Debra
Year of Publication 24.05.2018

Get full text

Patent

BUFFERED FORMULATIONS OF EXENDIN (9-39)

BUFFERED FORMULATIONS OF EXENDIN (9-39)

by ODINK, DEBRA, SMITH, CHRISTINE M.N, CRAIG, COLLEEN M, XIONG, XIAOFENG
Year of Publication 24.05.2018

Get full text

Patent

tratamento de eventos cardiacos adversos maiores e síndrome coronária aguda empregando-se terapias de combinação de inibidores de fosfolipase a2 secretória (spla2) ou inibidor de spla2

tratamento de eventos cardiacos adversos maiores e síndrome coronária aguda empregando-se terapias de combinação de inibidores de fosfolipase a2 secretória (spla2) ou inibidor de spla2

by Paul Truex, Joaquim Trias, Colin Hislop, Debra Odink
Year of Publication 28.03.2017

Get full text

Patent